By Dr. Shipra Gandhi Roswell Park Comprehensive Cancer Center Endocrine therapy is the mainstay of the management of hormone receptor (HR) positive breast cancer. Until now, fulvestrant remained the only selective
Presented by: Millie Das, MD Covered by: Ivy Riano, M.D., Research Chief Fellow, Hematology and Oncology Unit, Dartmouth Cancer Center, Lebanon, NH. Dr. Millie Das, Chief of Oncology at the Palo
MorePresented by: Alex A. Adjei, MD, PhD, FACP Covered by: Ivy Riano, M.D., Research Chief Fellow, Hematology and Oncology Unit, Dartmouth Cancer Center, Lebanon, NH. Dr. Alex A. Adjei, chair of
MoreSpeaker: Joshua Gruber, MD, PhD, Simmons Comprehensive Cancer Center Covered by: Inas Abuali, MD, FACP Dr. Gruber, from the Simmons Comprehensive Cancer Center, reviews basic science updates in precision oncology for breast
MorePresented by: Eric Collisson, MD, Professor of Medicine, Helen Diller Comprehensive Cancer Center Covered by: Inas Abuali, MD, FACP In the first half of this session, Dr. Collisson highlights the anatomic
MorePresented by: Chris Chen, MD, Director, Early Drug Development, Stanford Cancer Institute Covered by: Inas Abuali, MD, FACP Dr. Chris Chen, director of the Early Drug Development Program at Stanford Cancer Institute,
MorePresented by: Shaji Kumar, M.D., Mark and Judy. Mullins Professor of Hematological Malignancies. Chair, Myeloma and Amyloidosis Group, Mayo Clinic, Rochester, MN. Covered by: Abdul Moiz Khan, M.D, Chief Fellow of Hematology
MorePresented by: Michael A. Spinner, MD, Clinical Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD CAR T-cell therapy in hematologic malignancies has more options than ever before,
MorePresented by: Julia Carnevale, MD, Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD “Solid tumors are the next big frontier for cell therapies,” describes Dr. Julia Carnevale,
MorePresented by: Greg Allen, MD/PhD, Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD Dr. Greg Allen, assistant professor at the University of California San Francisco, delves into
MorePresented by: Christina Lockwood, PhD, Professor, University of Washington; Medical Director of Clinical Diagnostics, Brotman Baty Institute for Precision Medicine Covered by: Hannah Abrams, MD “Precision Oncology 101” begins with understanding
More